https://www.sowetanlive.co.za/news/africa/2022-12-23-biontech-initiates-clinical-trial-of-mrna-based-malaria-vaccine-candidate/
0
0
12/23/22 at 1:53pm
Organization
SowetanLIVE
Author
Reuters
37 words
0
Comments
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German company announced on Friday.
You are the first to view
Create an account
or login to join the discussion